CYNREN Launches Next Generation Advisory Firm Serving Family Offices, Funds and Institutions May 8, 2026 Founded by former partners of KPMG and Citibank with decades of experience guiding businesses, funds and families
AngloGold Ashanti Q1 31 March 2026 Earnings Release and Dividend Declaration May 8, 2026 AngloGold Ashanti delivers record free cash flow* of $1.2bn and EBITDA*(4) of $2.3bn • Gold production(1)(2) +1% • Net cash*(4) of $868m • Q1 2026 interim dividend of $585m, or 116 cps • Proposed $2.0bn share repurchase programme announced
Telekom Srbija Secures U.S. EXIM Financing to Accelerate 5G Rollout May 8, 2026 Approval from the Export-Import Bank of the United States will support Serbia’s next-generation telecoms expansion and strengthen U.S.–Serbia technology and economic ties
Sports industry braced for media rights dip, PwC report warns May 8, 2026 Sport bosses have warned that media rights are set to fall in value and can no longer be relied upon to drive growth across the industry. PwC’s Global Sports Survey of more than 500 senior executives found that growth was expected in all streams in the next three to five years, except media rights. Even [...]
Prothena Reports First Quarter 2026 Financial Results and Business Highlights May 7, 2026 Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used in operating and investing actives to be $18 to $23 million (versus prior guidance $50 to $55 million) and expects to end the year with approximately $273 million (midpoint) in cash, cash equivalents and restricted cash Novo Nordisk obtained Fast Track designation from the U.S. FDA for coramitug (PRX004) for the treatment of ATTR amyloidosis with cardiomyopathy and paid Prothena a $50 million clinical milestone payment related to Phase 3 enrollment Roche presented several clinical updates supporting the potential of prasinezumab for the treatment of Parkinson’s disease at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026) Prothena has completed the Phase 1 study for PRX019. Prothena could potentially earn a $55 million clinical milestone payment if Bristol Myers Squibb decides to advance the program; BMS decision expected by year-end 2026 Prothena initiated a share repurchase program to be conducted in 2026 for up to $100 million if deemed appropriate
83% of Restaurants Are Invisible in AI Search: New Uberall Report Reveals the Discovery Gap Reshaping the Quick Service Restaurant Industry May 7, 2026 Industry-first benchmark study analyzes how ChatGPT, Gemini, Perplexity, Copilot and Google AI Overviews recommend restaurants
Brent Hoberman: We need a ‘British dream’ – and more talented immigrants May 7, 2026 The UK needs to welcome many more business founders from abroad to rejuvenate the economy, one of Britain’s best-known entrepreneurs has said, as he issued a rallying cry to renew faith in the future of the country. In a wide-ranging speech at the City AM Awards ceremony at the Guildhall last night, Brent Hoberman, who [...]
Wunderkind and Bloomreach Launch Native Integration to Convert Anonymous Traffic into Revenue May 7, 2026 New integration brings Wunderkind’s identity and decisioning into Bloomreach, helping brands recognize more customers, enrich journeys, and drive incremental revenue — without changing workflows.
KBRA Releases Research – Sovereign Bond Supply Meets a More Demanding Market May 7, 2026 KBRA releases research examining how European and UK sovereign bond markets remain well supported, but are clearing at a higher cost. The report highlights that strong auction coverage and large order books continue to demonstrate deep demand, although elevated deficits, heavy redemptions, and quantitative tightening are keeping supply needs high. At the same time, limited [...]
Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing’s “Transistor Moment” May 7, 2026 Round co-led by DCVC and Kembara, with participation from the British Business Bank and Firgun, positions stealthy Quantum Motion as UK’s best-funded quantum computing company. Quantum Motion’s silicon transistor-based architecture produces quantum computers with 100-fold reduction in cost and space requirements as well as 1,000-fold reduction in energy consumption compared to other approaches.